Effects of Testosterone Supplementation for 3-Years on Muscle Performance and Physical Function in Older Men
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Context: Findings of studies of testosterone's effects on muscle strength and physical function in older men have been inconsistent; its effects on muscle power and fatigability have not been studied. Objective: To determine the effects of testosterone administration for 3 years in older men on muscle strength, power, fatigability, and physical function. Design, Setting, and Participants: This was a double-blind, placebo-controlled, randomized trial of healthy men ≥60 years old with total testosterone levels of 100 to 400 ng/dL or free testosterone levels <50 pg/mL. Interventions: Random assignment to 7.5 g of 1% testosterone or placebo gel daily for 3 years. Outcome Measures: Loaded and unloaded stair-climbing power, muscle strength, power, and fatigability in leg press and chest press exercises, and lean mass at baseline, 6, 18, and 36 months. Results: The groups were similar at baseline. Testosterone administration for 3 years was associated with significantly greater performance in unloaded and loaded stair-climbing power than placebo (mean estimated between-group difference, 10.7 W [95% confidence interval (CI), -4.0 to 25.5], P = 0.026; and 22.4 W [95% CI, 4.6 to 40.3], P = 0.027), respectively. Changes in chest-press strength (estimated mean difference, 16.3 N; 95% CI, 5.5 to 27.1; P < 0.001) and power (mean difference 22.5 W; 95% CI, 7.5 to 37.5; P < 0.001), and leg-press power were significantly greater in men randomized to testosterone than in those randomized to placebo. Lean body mass significantly increased more in the testosterone group. Conclusion: Compared with placebo, testosterone replacement in older men for 3 years was associated with modest but significantly greater improvements in stair-climbing power, muscle mass, and power. Clinical meaningfulness of these treatment effects and their impact on disability in older adults with functional limitations remains to be studied.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Three years of testosterone administration in patients with low levels of testosterone resulted in an increase in lean mass (0.9 kg, 95% CI 0.5–1.4; P < 0.001)412.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [412]
In the citing paper
“Several trials conducted with testosterone show a direct effect on muscle mass and, in several cases, on muscle strength and performance, with a slight reduction in body fat, and some effect on bone density [107-110].”
From Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review (2019) · cites this paper as [108]
Citations
Cites
Identification of late-onset hypogonadism in middle-aged and elderly men
Wu, F. C. W., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911101 · Cited by 1,544
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494 · cited 1×
“One test consisted of ascending the 12 steps as rapidly as possible without running (unloaded stair climb), whereas the second test required subjects to carry a load equivalent to 20% of their baseline body weight evenly distributed in 2 canvas tote bags (loaded stair climb) (13, 14).”
MethodSelf-citationHuman aging, muscle mass, and fiber type composition.
Evans, W. J., & Lexell, J. (1995) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/50a.special_issue.11 · Cited by 1,308 · cited 1×
“Aging is associated with a preferential loss of type II motor units (20, 31) and the consequent loss in the rate of force development (i.”
BackgroundProgressive resistance strength training for improving physical function in older adults
Liu, C.-J., & Latham, N. K. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002759.pub2 · Cited by 1,258
Muscle strength and speed of movement in relation to age and muscle morphology
Larsson, L., Grimby, G., & Karlsson, J. (1979) · Journal of Applied Physiology · doi:10.1152/jappl.1979.46.3.451 · Cited by 1,135 · cited 1×
“Aging is associated with a preferential loss of type II motor units (20, 31) and the consequent loss in the rate of force development (i.”
BackgroundLeg extensor power and functional performance in very old men and women.
Bassey, E. J., Fiatarone, M. A., O'neill, E. F., Kelly, M., Evans, W. J., & Lipsitz, L. A. (1992) · Clinical Science · doi:10.1042/cs0820321 · Cited by 943
Skeletal Muscle Power: A Critical Determinant of Physical Functioning in Older Adults
Reid, K. F., & Fielding, R. A. (2012) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e31823b5f13 · Cited by 913 · cited 2×
“Because muscle power is more strongly associated with functional performance in activities such as stair climbing, walking, and rising from a chair (22), assessing the effectiveness of anabolic therapies on muscle power is important.”
BackgroundMethodEffects of Testosterone Treatment in Older Men
Snyder, P. J., Bhasin, S., Cunningham, G. R., Matsumoto, A. M., Stephens-Shields, A. J., Cauley, J. A., Gill, T. M., Barrett-Connor, E., Swerdloff, R. S., Wang, C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506119 · Cited by 890 · cited 1×
“The findings of the TEAAM Trial, when viewed together with the recent results of the Testosterone Trials (TTrials) (34), suggest that testosterone replacement in community-dwelling older adults with either no functional limitations or with mild to moderate mobility limitation is associated with only modest improvement…”
ResultSelf-citationde Labra, C., Guimaraes-Pinheiro, C., Maseda, A., Lorenzo, T., & Millán-Calenti, J. C. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0155-4 · Cited by 709
Srinivas-Shankar, U., Roberts, S. A., Connolly, M. J., O'Connell, M. D. L., Adams, J. E., Oldham, J. A., & Wu, F. C. W. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1251 · Cited by 629
Cited by
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Sarcopenia and Cardiovascular Diseases
Damluji, A. A., Alfaraidhy, M., AlHajri, N., Rohant, N. N., Kumar, M., Al Malouf, C., Bahrainy, S., Ji Kwak, M., Batchelor, W. B., Forman, D. E., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.064071 · Cited by 645
Skeletal muscle atrophy: From mechanisms to treatments
Yin, L., Li, N., Jia, W., Wang, N., Liang, M., Yang, X., & Du, G. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105807 · Cited by 396
Sarcopenic obesity in older adults: a clinical overview
Prado, C. M., Batsis, J. A., Donini, L. M., Gonzalez, M. C., & Siervo, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00943-z · Cited by 355
“Of note, potential improvements in muscle (and lean) mass may not directly result in improved muscle function 214,215 .”
Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
Kirwan, R., McCullough, D., Butler, T., Perez de Heredia, F., Davies, I. G., & Stewart, C. (2020) · GeroScience · doi:10.1007/s11357-020-00272-3 · Cited by 324
“For example, long-term testosterone replacement therapy has been reported to increase lean body mass, muscle strength, and power in older men [102, 103].”
BackgroundRooks, D., Swan, T., Goswami, B., Filosa, L. A., Bunte, O., Panchaud, N., Coleman, L. A., Miller, R. R., Garcia Garayoa, E., Praestgaard, J., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.20836 · Cited by 177
the Sarcopenia Guidelines Development group of the Belgian Society of Gerontology and Geriatrics (BSGG), De Spiegeleer, A., Beckwée, D., Bautmans, I., & Petrovic, M. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0566-y · Cited by 160
Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview
He, N., Zhang, Y., Zhang, L., Zhang, S., & Ye, H. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.743710 · Cited by 157
“Decreased testosterone can cause fatigue and weakened exercise capacity, while testosterone supplementation can increase muscle strength and improve exercise capacity (111).”
BackgroundAging and the Male Reproductive System
Kaufman, J.-M., Lapauw, B., Mahmoud, A., T’Sjoen, G., & Huhtaniemi, I. T. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00178 · Cited by 144
Shin, M. J., Jeon, Y. K., & Kim, I. J. (2018) · The World Journal of Men's Health · doi:10.5534/wjmh.180001 · Cited by 134
“Some reported that muscle power was increased [38], while others reported that there was no difference in muscle strength [37,39], physical performance, activity or walking speed.”
BackgroundBiological basis and treatment of frailty and sarcopenia
Sato, R., Vatic, M., da Fonseca, G. W. P., Anker, S. D., & von Haehling, S. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae073 · Cited by 146
Mitochondrial function is impaired in the skeletal muscle of pre-frail elderly
Andreux, P. A., van Diemen, M. P. J., Heezen, M. R., Auwerx, J., Rinsch, C., Groeneveld, G. J., & Singh, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-26944-x · Cited by 106
Macdonald, S. H.-F., Travers, J., Shé, É. N., Bailey, J., Romero‐Ortuño, R., Keyes, M., O’Shea, D., & Cooney, M. T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228821 · Cited by 120
Sarcopenia, a condition shared by various diseases: can we alleviate or delay the progression?
Tarantino, G., Sinatti, G., Citro, V., Santini, S. J., & Balsano, C. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03339-z · Cited by 116
“Compared to placebo, testosterone replacement (7.5 g testosterone gel at 1% per day) in elder men with low to moderate–normal testosterone levels for 3 years was associated with modest but significantly greater improvements in muscle mass [74].”
BackgroundInfluentialBauer, J. M., Cruz-Jentoft, A. J., Fielding, R. A., Kanis, J. A., Reginster, J.-Y., Bruyère, O., Cesari, M., Chapurlat, R., Al-Daghri, N., Dennison, E., et al. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00561-w · Cited by 83
Role of hormones in sarcopenia
(2021) · Vitamins and Hormones · doi:10.1016/bs.vh.2020.12.021 · Cited by 92
Bhasin, S., Ellenberg, S. S., Storer, T. W., Basaria, S., Pahor, M., Stephens-Shields, A. J., Cauley, J. A., Ensrud, K. E., Farrar, J. T., Cella, D., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30171-2 · Cited by 87
Self-citationRelationship between Testosterone and Sarcopenia in Older-Adult Men: A Narrative Review
Shigehara, K., Kato, Y., Izumi, K., & Mizokami, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11206202 · Cited by 92
Alcazar, J., Guadalupe-Grau, A., García-García, F. J., Ara, I., & Alegre, L. M. (2018) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glx216 · Cited by 78
“Forty-six percent of the studies did not report information about drop outs/AEs, whereas 54% did (see Supplementary Table S2): 22 studies reported the occurrence of at least one AE (17,29,63–65,67,68,75,81– 83,87,91,93–101), 10 studies reported no AEs (31,61,62,77,89,102– 106), and three studies did not report whether…”
BackgroundSkinner, J. W., Otzel, D. M., Bowser, A., Nargi, D., Agarwal, S., Peterson, M. D., Zou, B., Borst, S. E., & Yarrow, J. F. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12291 · Cited by 76
“In our subgroup analysis, we included data from 19 of the studies mentioned in the preceding texts that limited enrolment to men ≥60 years of age, of which 9 administered intramuscular TRT28,31,16,33,35,15,17,49,53 and 10 administered transdermal TRT.38,40,13,42,44,45,11,50,14,55 We were unable to include the addition…”
InfluentialTreatment of sarcopenia: the road to the future
Morley, J. E. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12386 · Cited by 70
Furtner, J., Weller, M., Weber, M., Gorlia, T., Nabors, B., Reardon, D. A., Tonn, J. C., Stupp, R., & Preusser, M. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1987 · Cited by 79
Change in grip strength in trans people and its association with lean body mass and bone density
Scharff, M., Wiepjes, C. M., Klaver, M., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2019) · Endocrine Connections · doi:10.1530/ec-19-0196 · Cited by 64
McCullough, D., Webb, R., Enright, K. J., Lane, K. E., McVeigh, J., Stewart, C. E., & Davies, I. G. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09616-y · Cited by 62
Yan, X., Shen, Z.-L., Yu, D., Zhao, C., Zou, H., Ma, B., Dong, W.-X., Chen, W., Huang, D., & Yu, Z. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.11.030 · Cited by 65
Traustadóttir, T., Harman, S. M., Tsitouras, P. D., Pencina, K. M., Li, Z., Travison, T. G., Eder, R. V., Miciek, R., McKinnon, J., Woodbury, E. A., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01902 · Cited by 60
Self-citationBhasin, S., Lincoff, A. M., Nissen, S. E., Wannemuehler, K. A., McDonnell, M. E., Peters, A. L., Khan, N., Snabes, M. C., Li, X., Li, G., et al. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.7862 · Cited by 65
Self-citationGoeury, K., Duy, S. V., Munoz, G., Prévost, M., & Sauvé, S. (2022) · Talanta · doi:10.1016/j.talanta.2022.123216 · Cited by 59
Parahiba, S. M., Ribeiro, É. C. T., Corrêa, C., Bieger, P., Perry, I. D. S., & Souza, G. C. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111106 · Cited by 66
The Therapeutic Intervention of Sex Steroid Hormones for Sarcopenia
Huang, L., & Wang, J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.739251 · Cited by 65
“However, the effects observed on muscle performance and physical function were inconsistent due to the different treatment methods employed (47, 48, 50, 51).”
MethodGellhaus, B., Böker, K. O., Schilling, A. F., & Saul, D. (2023) · Cells · doi:10.3390/cells12242787 · Cited by 60
“Moreover, its application for 36 months, also in male subjects ( ≥ 60 years, n = 256), led to increased stair-climbing power, muscle strength, and lean body mass [29].”
BackgroundFurtner, J., Weller, M., Weber, M., Gorlia, T., Nabors, B., Reardon, D. A., Tonn, J. C., Stupp, R., & Preusser, M. (2021) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-209414 · Cited by 50
Is Testosterone Replacement Therapy in Older Men Effective and Safe?
Yabluchanskiy, A., & Tsitouras, P. D. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00716-2 · Cited by 53
“5 g of 1% testosterone gel, on lean body mass in 135 community-dwelling older men over 60 years of age with baseline total testosterone levels of 100–400 ng/dL and free testosterone of <50 pg/mL [24].”
Self-citationCho, J., Choi, Y., Sajgalik, P., No, M., Lee, S.-H., Kim, S., Heo, J., Cho, E., Chang, E., Kang, J., et al. (2020) · Cells · doi:10.3390/cells9102284 · Cited by 47
Saha, S., Goswami, R., Ramakrishnan, L., Vishnubhatla, S., Mahtab, S., Kar, P., Srinivasan, S., Singh, N., & Singh, U. (2018) · Clinical Endocrinology · doi:10.1111/cen.13507 · Cited by 44
Skeletal muscle dysfunction with advancing age
Pabla, P., Jones, E. J., Piasecki, M., & Phillips, B. E. (2024) · Clinical Science · doi:10.1042/cs20231197 · Cited by 55
“Testosterone in particular is the male sex hormone, and following declining endogenous levels with advancing age, exogenous supplementation in older men has been shown to elicit increases in muscle mass and strength [228,229].”
BackgroundTestosterone Replacement, Muscle Strength, and Physical Function
Nam, Y., Lee, G., Yun, J. M., & Cho, B. (2018) · The World Journal of Men s Health · doi:10.5534/wjmh.182001 · Cited by 44
“The other primary and secondary outcomes investigated in each of the studies are listed in Table 1 [2,7-9,14-27].”
BackgroundGiagulli, V. A., Castellana, M., Murro, I., Pelusi, C., Guastamacchia, E., Triggiani, V., & Pergola, G. D. (2019) · Nutrients · doi:10.3390/nu11122975 · Cited by 45
Huang, G., Pencina, K. M., Li, Z., Basaria, S., Bhasin, S., Travison, T. G., Storer, T. W., Harman, S. M., & Tsitouras, P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02545 · Cited by 40
Self-citationFreystaetter, G., Fischer, K., Orav, E. J., Egli, A., Theiler, R., Münzer, T., Felson, D. T., & Bischoff-Ferrari, H. A. (2020) · Arthritis Care & Research · doi:10.1002/acr.24074 · Cited by 42
“11 57 (21) 1 33 (53) 29 (47) – 62 (23) 2 18 (33) 36 (67) – 54 (20) 3 31 (42) 42 (58) – 73 (27) 4 12 (50) 12 (50) – 24 (9) WOMAC pain score (0–100) Operated knee 23.”
BackgroundChasland, L. C., Yeap, B. B., Maiorana, A., Chan, Y. X., Maslen, B. A., Cooke, B. R., Dembo, L. G., Naylor, L. H., & GREEN, D. J. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00010.2021 · Cited by 46
Falqueto, H., Júnior, J. L. R., Silvério, M. N. O., Farias, J. C. H., Schoenfeld, B. J., & Manfredi, L. H. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09634-4 · Cited by 48
“Elderly individuals who underwent a 3-year hormone therapy replacement regimen exhibited similar results [86].”
ResultBhasin, S., Krishnan, V., Storer, T. W., Steiner, M., & Dobs, A. S. (2023) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glad027 · Cited by 36
Self-citationHuang, K., Cai, H., Bao, J., & Wu, L. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101132 · Cited by 40
Muscle quality index and cardiovascular disease among US population-findings from NHANES 2011–2014
Chen, Y., Lin, W., Fu, L., Liu, H., Jin, S., Ye, X., Pu, S., & Xue, Y. (2023) · BMC Public Health · doi:10.1186/s12889-023-17303-1 · Cited by 39
“Additionally, oral testosterone supplementation has been shown to increase muscle mass and strength [45, 46], although its effect on CHF requires further investigation.”
BackgroundNightingale, T. E., Moore, P. D., Harman, J., Khalil, R. E., Gill, R. S., Castillo, T. A., Adler, R. A., & Gorgey, A. S. (2017) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2017.1357917 · Cited by 37
Sarcopenia versus cancer cachexia: the muscle wasting continuum in healthy and diseased aging
Moreira‐Pais, A., Ferreira, R. M., Oliveira, P. A., & Duarte, J. A. (2021) · Biogerontology · doi:10.1007/s10522-021-09932-z · Cited by 34
Diago-Galmés, A., Guillamón-Escudero, C., Tenías, J. M., Soriano, J. M., & Garrido, J. F. (2021) · Biology · doi:10.3390/biology10020093 · Cited by 35
Alexander, S. E., Gatto, B., Knowles, O., Williams, R. M., Fiebig, K. N., Jansons, P., Gatta, P. A. D., GARNHAM, A. P., Eynon, N., Wadley, G. D., et al. (2024) · The Journal of Physiology · doi:10.1113/jp286803 · Cited by 35
Jasuja, G. K., Ameli, O., Reisman, J. I., Rose, A. J., Miller, D. R., Berlowitz, D. R., & Bhasin, S. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.17141 · Cited by 30
Self-citationYao, J., Wang, Y., Yang, L., Ren, M., Li, L., & Wang, H. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-067425 · Cited by 33
Fernández, T., Briceño, F. A. C., Espinosa‐Ramírez, M., García-Valdés, P., López‐Fuenzalida, A., Riquelme, A. J., Arab, J. P., Cabrera, D., Arrese, M. A., & Francisco Barrera, M. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1810563 · Cited by 29
“associated with improvement in physical performance and beneficial cardiovascular effects [142,143].”
BackgroundTestosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model
Sarchielli, E., Comeglio, P., Filippi, S., Cellai, I., Guarnieri, G., Guasti, D., Rapizzi, E., Rastrelli, G., Bani, D., Vannelli, G. B., et al. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0532 · Cited by 27
Role of testosterone in cognition and mobility of aging men
Kaufman, J., & Lapauw, B. (2020) · Andrology · doi:10.1111/andr.12872 · Cited by 32
Testosterone replacement in aging men: an evidence-based patient-centric perspective
Bhasin, S. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146607 · Cited by 32
Self-citationOsteosarcopenia in NAFLD/MAFLD: an underappreciated clinical problem in chronic liver disease
Musio, A., Perazza, F., Leoni, L., Stefanini, B., Dajti, E., Menozzi, R., Petroni, M. L., Colecchia, A., & Ravaioli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087517 · Cited by 26
“Since testosterone treatment in older adults was associated with increased muscle mass [250] and improved physical performance [251,252], this hormonal therapy has been evaluated to treat sarcopenia in LC patients.”
BackgroundXia, K., Chen, H., Wang, J., Feng, X. G., Gao, Y., Wang, Y., Deng, R., Wu, C., Luo, P., Zhang, M., et al. (2020) · Theranostics · doi:10.7150/thno.46854 · Cited by 27
“The clinical features of TD include sexual dysfunction [5], obesity [2], muscle weakness [6, 7], osteoporosis [8, 9] and others.”
BackgroundMagnussen, L. V., Hvid, L. G., Hermann, A., HOUGAARD, D. M., Gram, B., Caserotti, P., & Andersen, M. (2017) · Andrology · doi:10.1111/andr.12396 · Cited by 29
“…al., 2008), and despite some minor inconsistencies, these adaptations have subsequently been shown to translate into improvements in muscle mechanical function and physical function in healthy aging men (Isidori et al., 2005; Storer et al., 2008, 2016; Bhasin et al., 2012; Hildreth et al., 2013).”
ResultTestosterone Treatment in Middle-Aged and Older Men with Hypogonadism
Bhasin, S., & Snyder, P. J. (2025) · New England Journal of Medicine · doi:10.1056/nejmra2404637 · Cited by 32
Self-citationLate-onset hypogonadism: Clinical evidence, biological aspects and evolutionary considerations
Jaschke, N., Wang, A., Hofbauer, L. C., Rauner, M., & Rachner, T. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101301 · Cited by 30
Physiological basis behind ergogenic effects of anabolic androgens
Cheung, A. S., & Grossmann, M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.047 · Cited by 34
Liang, Z., & Zhang, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1733798 · Cited by 39
“Several reviews and meta-analyses have indicated that testosterone improves body composition in older hypogonadal men by increasing lean mass and reducing fat mass (Snyder et al., 2016; Storer et al., 2017; Midttun et al., 2024).”
Andrade, S. R. D. L., Mucida, Y. M., Xavier, J. D. C., Fernandes, L. N., Silva, R. D. O., & Bandeira, F. A. F. (2021) · Steroids · doi:10.1016/j.steroids.2021.108951 · Cited by 26
Huang, K., Chiang, Y., Ali, M. R., & Hsia, S. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13817 · Cited by 29
“It stimulates muscle synthesis proteins and enhances grip strength and muscle mass [84].”
Klotho: An Emerging Factor With Ergogenic Potential
Arroyo, E., Troutman, A. D., Moorthi, R. N., Avin, K. G., Coggan, A. R., & Lim, K. J. (2022) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2021.807123 · Cited by 27
Boogers, L. S., Reijtenbagh, S. J. P., Wiepjes, C. M., van Trotsenburg, A. S. P., den Heijer, M., & Hannema, S. E. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad750 · Cited by 26
Testosterone, frailty and physical function in older men
Hsu, B., Cumming, R. G., & Handelsman, D. J. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1475227 · Cited by 25
New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men
Karakas, S. E., & Surampudi, P. N. (2018) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.06.001 · Cited by 25
Naringenin improves muscle endurance via activation of the Sp1-ERRγ transcriptional axis
Lv, Z., Meng, J., Yao, S., Xiao, F., Li, S., Shi, H., Cui, C., Chen, K., Luo, X., Ye, Y., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113288 · Cited by 23
Buratto, J., Kirk, B., Phu, S., Vogrin, S., & Duque, G. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.04.013 · Cited by 22
Zhang, W., Cui, Z., Shen, D., Li, G., & Li, Q. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1512268 · Cited by 24
Morimoto, M., Yamaoka, M., & Hara, T. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.563 · Cited by 24
Lee, T.-W., Kao, P., Chen, Y., & Wang, S. (2023) · Gerontology · doi:10.1159/000532062 · Cited by 23
Androgen and estrogen actions on male physical activity: a story beyond muscle
Jardí, F., Laurent, M. R., Dubois, V., Kim, N., Khalil, R., Decallonne, B., Vanderschueren, D., & Claessens, F. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0125 · Cited by 24
Moser, V., Christensen, A., Liu, J., Zhou, A.-J., Yagi, S., Beam, C., Galea, L., & Pike, C. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.09.016 · Cited by 19
“However, consistent with an increasing literature on effects of testosterone in aging men (Emmelot-Vonk et al., 2008; Snyder et al., 2018; Storer et al., 2017), our findings in aging rats do not indicate robust benefits of testosterone supplementation.”
BackgroundTestosterone therapy in older men: clinical implications of recent landmark trials
Grossmann, M., Anawalt, B. D., & Yeap, B. B. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae071 · Cited by 21
Gagliano‐Jucá, T., Li, Z., Pencina, K. M., Traustadóttir, T., Travison, T. G., Woodhouse, L. J., Basaria, S. S., Tsitouras, P. D., Harman, S. M., Bhasin, S., et al. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz167 · Cited by 24
“Methods Subjects The data for the SCP test were collected in two randomized controlled trials in older men investigating the efficacy of a transdermal testosterone gel in improving lean mass, muscle performance, and physical function; the Testosterone in Older Men with Mobility Limitation (TOM) (13,18) (N = 146), and…”
MethodSelf-citationLost in translation: challenges of current pharmacotherapy for sarcopenia
Tsai, S. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.05.016 · Cited by 20
Factors, mechanisms and improvement methods of muscle strength loss
Wang, K., Wang, X., & Wang, Y. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1509519 · Cited by 23
Ren, X., Guan, Z., Zhao, X., Zhang, X., Wen, J., Cheng, H., Zhang, Y., Cheng, X., Liu, Y., Ning, Z., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065868 · Cited by 15
“The role of testosterone is mainly manifested in cognitive functions [41], muscle mass and power [42], and mood adjustments [43].”
BackgroundOptimizing Diagnostic Accuracy and Treatment Decisions in Men With Testosterone Deficiency
Bhasin, S., & Ozimek, N. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.08.002 · Cited by 15
Self-citationFu, S., Lin, X., Yin, L., & Wang, X. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00610-y · Cited by 16
Role of circulating molecules in age-related cardiovascular and metabolic disorders
Hsiao, Y., Shimizu, I., Yoshida, Y., & Minamino, T. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-021-00187-2 · Cited by 16
Falqueto, H., dos Santos, M. R., & Manfredi, L. H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.838526 · Cited by 18
Benefits and Risks of Testosterone Treatment of Older Men with Hypogonadism
Galbiati, F., Goldman, A. L., Gattu, A. K., Guzelce, E. C., & Bhasin, S. (2022) · Urologic Clinics of North America · doi:10.1016/j.ucl.2022.07.011 · Cited by 16
Self-citationTherapeutic effects of androgens for cachexia
Giovanelli, L., & Quinton, R. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101598 · Cited by 15
Anstey, M., Desai, S., Torre, L. E., Wibrow, B. A., Seet, J., & Osnain, E. (2018) · Case Reports in Critical Care · doi:10.1155/2018/4545623 · Cited by 16
“Testosterone supplementation in older healthy men has been shown to have benefits on physical functioning, including improved fat-free mass and muscle strength [9, 10].”
BackgroundDrugs of Muscle Wasting and Their Therapeutic Targets
Sakuma, K., & Yamaguchi, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_21 · Cited by 14
Hoermann, R., Fui, M. N. T., Krakauer, J. C., Krakauer, N. Y., & Grossmann, M. (2019) · International Journal of Obesity · doi:10.1038/s41366-018-0311-y · Cited by 15
Late-Onset Hypogonadism as Primary Testicular Failure
Swee, D. S., & Gan, E. H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00372 · Cited by 13
Trials of testosterone replacement reporting cardiovascular adverse events
Basaria, S. S., & Gagliano‐Jucá, T. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_28_17 · Cited by 12
Self-citationAn, K.-O., & Kim, J. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17010269 · Cited by 11
“intervention study showed that taking testosterone supplementation for three years improved muscle performance and physical function in the elderly population [40].”
BackgroundImprovement of testosterone deficiency by fermented Momordica charantia extracts in aging male rats
Lee, K.-S., Kim, H. P., Park, H., & Yoon, Y. (2021) · Food Science and Biotechnology · doi:10.1007/s10068-020-00872-x · Cited by 10
“The direct correlation between the MEs and muscle mass increase has not yet been reported, but considering the findings of previous studies reporting that testosterone replacement increased the femoral muscle mass in aging men (Borst and Yarrow, 2015; Storer et al., 2017), the increase in testosterone content is thoug…”
BackgroundResultDias, J. P., Piggott, D. A., Sun, J., Wehbeh, L., Garza, J., Abraham, A. G., Astemborski, J. A., Moseley, K. F., Basaria, S. S., Varadhan, R., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac144 · Cited by 6
Self-citationBak, J., Lee, S. J., Kim, T. W., Hwang, S., Park, M. J., Arunachalam, R., Yoo, E., Park, M. H., Choi, Y.-S., & Kim, H. K. (2023) · Nutrition Research and Practice · doi:10.4162/nrp.2023.17.1.1 · Cited by 11
“Hypogonadism results in several diseases such as sexual dysfunction, depression, difficulty concentrating, and muscle weakness [3-6].”
BackgroundRisks of Serious Injury with Testosterone Treatment
Yarnell, C. J., Thiruchelvam, D., & Redelmeier, D. A. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.07.037 · Cited by 10
Mouse testicular macrophages can independently produce testosterone and are regulated by Cebpb
Duan, N., Ran, Y., Wang, H., Luo, Y. L., Gao, Z., Lu, X., Cui, F., Chen, Q., Xue, B., & Liu, X. (2024) · Biological Research · doi:10.1186/s40659-024-00544-8 · Cited by 9
“Additionally, it has significant effects on health for both males and females, including the regulation of libido, strength, immune function, hematopoietic function, and resistance to osteoporosis [2–5].”
BackgroundConnolly, M. J., Kerse, N. M., WILKINSON, T. J., Menzies, O. H., Rolleston, A. K., Chong, Y. H., Broad, J., Moyes, S. A., Jatrana, S., & Teh, R. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016572 · Cited by 8
“16 Another reported an increase in grip strength(19) A very recent study, also over 3 years, showed that T supplementation improved some (not all) measures of muscle strength, but that any beneficial effect ‘appeared to wane over time’.(20) Important concerns about longer-term safety remain, most particularly with reg…”
BackgroundA Content Analysis of Testosterone Websites: Sex, Muscle, and Male Age-Related Thematic Differences
Ivanov, N., Vuong, J., & Gray, P. B. (2017) · American Journal of Men s Health · doi:10.1177/1557988317734667 · Cited by 9
“Three years of testosterone replacement therapy in older men was associated with improvements in chest press, muscle power, stair-climbing power, and lean body mass (Storer et al., 2016).”
BackgroundDrugs for the Treatment of Muscle Atrophy
Chen, L., Zhang, H., Chi, M., Yang, Q., & Guo, C. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.93503 · Cited by 12
Metadata
- Authors
- Storer, T. W., Basaria, S., Traustadottir, T., Harman, S. M., Pencina, K., Li, Z., Travison, T. G., Miciek, R., Tsitouras, P., Hally, K., Huang, G., & Bhasin, S.
- Affiliations
- Brigham and Women's Hospital (US)
- Phoenix VA Health Care System (US)
- Boston University (US)
- Kronos Longevity Research Institute (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-10-18
- Volume
- 102
- Issue
- 2
- Pages
- jc.2016-2771
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC5413164
- OpenAlex
- W2532193123
- Cited by
- 174
- References
- 37
- Citations by year
- 2026: 9 · 2025: 22 · 2024: 19 · 2023: 25 · 2022: 16 · 2021: 25 · 2020: 17 · 2019: 11 · 2018: 21 · 2017: 9
- FWCI
- 13.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p30ag031679-15)
- National Institute on Aging (P30-AG031679)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- testosterone replacement therapy, older men, muscle strength, muscle power, fatigability, physical function, lean body mass, chest press, leg press, transdermal testosterone gel, hypogonadism
- MeSH terms
- Aged, Aging, Body Composition, Double-Blind Method, Humans, Male, Middle Aged, Physical Fitness, Testosterone, Body Mass Index, Outcome Assessment, Health Care, Muscle, Skeletal, Hormone Replacement Therapy, Muscle Strength
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.